InvestorsHub Logo

LORTAP KCOTS

05/01/21 6:53 AM

#5881 RE: Moonboy1 #5879

Sounds like you really want to prove you are right, to whom is the actual question?

LORTAP KCOTS

05/01/21 6:54 AM

#5882 RE: Moonboy1 #5879

Also I haven’t found a single rating yet, so I believe you are not telling the truth on this.

Nelson2

05/01/21 7:33 AM

#5883 RE: Moonboy1 #5879

Come on man!
In the market today stocks move on innuendo, rumors and “betting” on future potential
Basic investing principles won’t return until another crash
This PPS blows my mind!

WTF!

GLTA

MomsSpaghetti

05/01/21 7:42 AM

#5884 RE: Moonboy1 #5879

May I ask what clinical stage biotech then would have a buy rating. Almost all of them have no revenue and surely not all of them fail.

ypanoodle

05/01/21 11:02 AM

#5886 RE: Moonboy1 #5879

You are taking a very short term mindset on a long term stock/gamble...this sector is in its infancy...plenty of pot stocks were in this same situation years ago before exploding...I see this as the same kind of play...will go down a little before going up a lot...LOL

Bruinfan4ever

05/01/21 11:31 AM

#5887 RE: Moonboy1 #5879

A sell by many analysts? LOL. Analysts haven't even looked into this stock. Many analysts give a buy rating to Compass anywhere from 65-88 stock price. And Compass isn't any further along. Mindmed has a lot more in their pipeline than Compass.


"Many Analysts". LMAO

Bruinfan4ever

05/01/21 11:34 AM

#5888 RE: Moonboy1 #5879

Consider me an analyst because I have been following this stock for awhile and I probably know more than these analysts you speak of. I put a buy rating of 10-15 short term.